Know Labs Unveils KTL: A Game Changer for RFDS Technology

Know Labs, Inc. (NYSE American: KNW), a trailblazer in the development and application of Radio Frequency Dielectric Spectroscopy (RFDS), has announced the formation of its new business unit, Know Labs Technology Licensing (KTL). Modeled after the successful Qualcomm Technology Licensing (QTL) framework, KTL is dedicated to licensing Know Labs' robust intellectual property (IP) portfolio to corporate partners, academic institutions, and research organizations. This strategic move aims to foster innovation and accelerate the adoption of RFDS platform technology across a broad range of industries and the academic and scientific ecosystem.



The launch of KTL represents a pivotal milestone in Know Labs' strategic growth plan. While the company remains focused on leveraging RFDS for transformative applications in non-invasive medical diagnostics, with a first focus on blood glucose monitoring, KTL will unlock additional value by enabling external partners to integrate RFDS technology into applications spanning industrial processes, consumer electronics, automotive advancements, and Internet-of-Things (IoT) networks.

Ron Erickson, CEO and Chairman at Know Labs, expressed his enthusiasm about the creation of KTL: "With the formation of KTL, we are taking a bold step forward to amplify the reach and impact of our RFDS platform. This initiative not only positions Know Labs as a patent licensing leader in advanced RF spectroscopy technology but also opens the door for collaborative innovation in industries far beyond medical diagnostics."



KTL will operate with a dual focus: monetizing Know Labs' IP assets to generate licensing revenues and creating widespread adoption of RFDS technology as an industry standard. This move aligns with Know Labs' commitment to delivering shareholder value while advancing groundbreaking technology that addresses real-world challenges. KTL is a direct response to unsolicited inbound demand, demonstrating the strong interest in Know Labs' RFDS technology across various industries.

One of the key opportunities presented by KTL is the commercialization of a 'mart steering wheel' for safety applications in the automotive industry, which advances Know Labs' leadership in automotive medical IoT sensors. Additionally, the company sees potential in leveraging its RFDS technology as a highly sensitive 'change or difference detector' for various industrial processes and working with academic institutions to commercialize its patented data collection application development platform for use in clinical research.



In conclusion, the launch of Know Labs Technology Licensing (KTL) is a significant development for the company and the broader RFDS technology ecosystem. By monetizing its IP assets and fostering widespread adoption of RFDS technology, Know Labs is poised to generate shareholder value while addressing real-world challenges across various industries. As the company continues to innovate and collaborate with partners, investors should keep a close eye on Know Labs' progress and the potential impact of KTL on the market.